Home
>
National Drug Code (NDC)
>
METOPiRONE
METOPiRONE - 76336-455-17 - (Metyrapone)
Drug Information of METOPiRONE
| Product NDC: | 76336-455 |
| Proprietary Name: | METOPiRONE |
| Non Proprietary Name: | Metyrapone |
| Active Ingredient(s): | 250 mg/1 & nbsp; Metyrapone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of METOPiRONE
| Product NDC: | 76336-455 |
| Labeler Name: | HRA Pharma |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012911 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111001 |
Package Information of METOPiRONE
| Package NDC: | 76336-455-17 |
| Package Description: | 18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-17) |
NDC Information of METOPiRONE
| NDC Code | 76336-455-17 |
| Proprietary Name | METOPiRONE |
| Package Description | 18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-17) |
| Product NDC | 76336-455 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metyrapone |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20111001 |
| Marketing Category Name | NDA |
| Labeler Name | HRA Pharma |
| Substance Name | METYRAPONE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenal Steroid Synthesis Inhibitor [EPC],Adrenal Steroid Synthesis Inhibitors [MoA] |
